BACKGROUND AND PURPOSE:Although the natural course of UIAs remains unclear, the risk of aneurysmal SAH due to small (Ͻ10 mm) asymptomatic UIAs is low. Endovascular therapy for UIAs has increased because of device development and the need for less invasive treatment. We report the results, safety, and efficacy of endovascular therapy of small asymptomatic UIAs.